Israel Venture Capital Investments Report Q3 2017

Similar documents
IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

IVC-MEITAR HIGH-TECH EXITS 2015 REPORT 2015 exits peak at $9.02B 3 rd strongest year in 10 years

Silicon Valley Venture Capital Survey Second Quarter 2018

MoneyTreeTM. Report. Some $171 million VC financing invested in hi-tech companies in Q compared with $255 million in the second quarter 2012

2013 venture capital trends summary

Silicon Valley Venture Capital Survey Third Quarter 2017

The percentage of Series A rounds declined significantly, to 12% of all deals.

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

Venture Capital Industry Overview. Powered By:

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

Technologies Worth Watching. Case Study: Investigating Innovation Leader s

VENTURE CAPITAL MONITOR

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

Venture Capital Report

Raising capital Healthy fundraising tension shows the market s underlying strength

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Digital Health Funding and M&A

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

Venture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12.

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

Venture Capital Search Highlights

Trends in Healthcare Investments and Exits 2018

NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD

Q INTRODUCTION VC ACTIVITY OVERVIEW. Summary of investment and fundraising. ($ millions)

2011 Angel Group Year in Review

Guidelines to Promote National Integrated Circuit Industry Development : Unofficial Translation

FINC915 Venture Lab Participating Firms: FALL 2010

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

Venture Capital Research Report Q4 2017

MoneyTree Report Q PricewaterhouseCoopers National Venture Capital Association. Data provide by Thomson Reuters.

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Private Equity Market Update. February 2013

Q Introduction. Summary of investment and fundraising. Deal size. Increase in deal size.

Angel Group Update: Q2 2013

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

Thelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT. J. Thelander Consulting

2013 Global venture capital confidence survey results. How confident are investors?

Overview of Venture Equity

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

Average M&A Deal Size at Highest Level Since 2004

Financing Baltimore s Growth: Venture Capital Support for Small Companies

2017 Venture Capital Update. Bobby Franklin President & CEO, National Venture Capital Association (NVCA) January 2017

Mary Macdonald November 2005

Q Introduction. Investment and fundraising

Mara H. Rogers, Partner Norton Rose Fulbright

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

ECSEL JU Symposium 2018 Electronics: a vision and how to get there Lessons learned from study on access-to-finance conditions. Brussels, June

Give Me 5: GENDER LENS INVESTING: THE RISING TIDE OF WOMEN ANGELS

2018 PHILADELPHIA VENTURE REPORT

Life Sciences Outlook. New York City 2016

Venture Capital Report

Silicon Valley Venture Capital Survey Third Quarter 2017

Year In Review: 2017 Edition

Venture Capital Report

Q INTRODUCTION VC ACTIVITY OVERVIEW. Investment and fundraising. Deal size.

Q INTRODUCTION VC ACTIVITY OVERVIEW. Summary of investment and fundraising. Deal size.

FINC915 Venture Lab Participating Firms: FALL 2009

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Innovation Ecosystem in the USA Rui Boavista Marques

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

Silicon Valley Venture Capital Survey Fourth Quarter 2018

ENTREPRENEURSHIP & ACCELERATION

Information Technology: McGladrey Quarterly Private Equity Deal Flow Profile

A report on investment gender diversity in the Nordics

The Danish-American Entrepreneurship Summit

Insight: Measuring Manhattan s Creative Workforce. Spring 2017

presents THE ANGEL CONNECTION

Service Science: A Key Driver of 21st Century Prosperity

VentureSource China -- 3Q 2014

Inbound Flip Transactions

Venture Capital Report

Venture funding for innovative / technology based business

Venture Capital Report

CDFA / / BNY MELLON DEVELOPMENT FINANCE WEBCAST SERIES Publicly Supported Seed & Venture Capital

JAFCO Investment (Hong Kong) Ltd.

Private Equity Market and Trends Brigitte Baumann CEO Go Beyond; President of EBAN

VENTURE CAPITAL MONITOR

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

SEMICONDUCTOR INDUSTRY ASSOCIATION FACTBOOK

KTO co-operation with venture capitalists how to design effectively?

1Q04 Update: Silicon Demand Will Move to a Full Recovery

Financing Entrepreneurship: Is Gender an Issue?

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

Accenture Technology Vision 2015 Delivering Public Service for the Future Five digital trends: A public service outlook

Venture Capital Report

The Great Convertible Note Debate What New Angels Need to Know

P r e s e n t a t i o n. We are an independent and China-based corporate law firm. We make sure you successfully reach your goals in China.

Technology, Media. Telecom. Practice. Group. tions including mergers, acquisitions, joint ventures, debt, equity, and lease financing.

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

VentureSource U.S. -- 4Q 2013

The Economic Contribution of Canada s R&D Intensive Enterprises Dr. H. Douglas Barber Dr. Jeffrey Crelinsten

Choosing the Right Partner for Global Expansion. Oded Shenkar & Lou Longo

Digital Health Startups A FirstWord ExpertViews Dossier Report

Winter 2004/05. Shaping Oklahoma s Future Economy. Success Stories: SemGroup, SolArc Technology Yearbook

21 st CEO Survey CEOs sound a note of optimism. Key findings from the oil and gas industry. ceosurvey.pwc

Q Q Cleantech Investment Monitor VOL. 7 / ISSUE 1.

Hellenic Technology Clusters Initiative

Transcription:

Israel Venture Capital Investments Report Q3 2017 NOVEMBER 2017

Summary of Israeli Venture Capital Raising Q3/2017 +14% from Q2/2017 Israeli high-tech capital raising summed up to $1.44B @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 2

Israeli high-tech capital raising Q3/2017 In Q3/2017, $1.44 billion were raised by 144 Israeli hightech companies, an increase of 14 percent over the $1.27 billion raised in Q2/2017, and a 54 percent surge from $933 million raised in Q3/2016. The number of deals, however, decreased somewhat in Q3/2017. The average financing round reached a five-year high of $10 million. $m # 250 1600 1400 1200 1000 168 141 164 193 160 175 168 181 163 179 162 202 174 194 140 166 155 158 144 200 150 800 600 400 200 439 481 663 821 672 934 699 1,104 1,001 1,142 1,035 1,129 1,110 1,714 933 1,073 1,060 1,266 1,439 100 50 0 0 Total Amount $m # of Deals Source: IVC-ZAG HT Survey Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 3

Average financing of Israeli high-tech company Q3/2017 $m 12.00 10.00 9.99 8.83 8.02 8.00 6.00 5.33 6.10 6.14 6.38 6.39 5.59 6.38 6.66 6.46 6.84 4.00 3.41 4.04 4.25 4.20 4.16 2.61 2.00 - Average Source: IVC-ZAG HT Survey Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 4

Israeli high-tech capital raising Q1-Q3/2017 In the first nine months of 2017, Israeli high-tech companies attracted $3.8 billion, equal to the corresponding period of 2016. The number of deals in Q1-Q3/2017, however 457 deals in total declined to the lowest in the past five years. The average VC-backed financing round has been continuously increasing over the past five years to peak at $10.4 million in Q1-Q3/2017, compared with $8.4 million in Q1-Q3/2016. $m # 4000 600 3500 3000 473 503 504 508 457 500 2500 400 2000 1500 1000 500 1,583 2,304 3,178 3,757 3,766 300 200 100 0 Q1-Q3/2013 Q1-Q3/2014 Q1-Q3/2015 Q1-Q3/2016 Q1-Q3/2017 Total Amont # of Deals Source: IVC-ZAG HT Survey Q3/2017 0 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 5

Israeli VC-Backed Transactions +73% from 5-year average VC-backed deals peaked at $1.2 billion in Q3/2017 the highest in past 5 years @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 6

Israeli VC-backed deals Q3/2017 In Q3/2017, capital raised in VC-backed deals continued to grow, reaching $1.2 billion raised in 89 deals. The amount was 32 percent up from the $924 million raised in Q2/2017, and 95 percent above the $622 million raised in Q3/2016. The VC-backed share of total capital increased gradually throughout the first three quarters of 2017, to account for 84 percent in Q3/2017, compared with 67 percent in Q3/2016. The number of VC-backed deals in Q3/2017, however, was 9 percent below the quarterly average of past five years. The average VC-backed financing round peaked at $13.7 million in Q3/2017, compared with $9 million in Q2/2017, and the $8 million average in Q3/2016. $m # 1800 1600 1400 1200 1000 800 95 80 100 663 821 25% 114 77 672 108 934 43% 89 699 107 1,104 92 1,001 24% 15% 99 100 1,142 54% 115 100 1,129 1,110 1,035 16% 24% 30% 124 33% 1,714 78 103 1,439 95 86 1,073 1,060 933 33% 34% 29% 1,266 27% 125 105 89 16% 85 65 45 600 439 481 31% 31% 33% 25 400 32% 23% 200 0 68% 77% 69% 75% 69% 57% 67% 76% 85% 46% 84% 76% 70% 67% 67% 66% 71% 73% 84% 2013/1 2013/2 2013/3 2013/4 2014/1 2014/2 2014/3 2014/4 2015/1 2015/2 2015/3 2015/4 2016/1 2016/2 2016/3 2016/4 2017/1 2017/2 2017/3 5-15 % of Non VC-backed Amount $m VC-backed Amount $m # of VC-backed Deals Source: IVC-ZAG HT Survey Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 7

Israeli VC-backed deals capital raising Q1-Q3/2017 $m # 3500 3000 275 274 291 302 278 350 300 2500 250 2000 200 1500 1000 500 1,127 1,469 2,243 2,549 2,893 150 100 50 0 0 Q1-Q3/2013 Q1-Q3/2014 Q1-Q3/2015 Q1-Q3/2016 Q1-Q3/2017 VC-backed Amount $m # of VC-backed Deals Source: IVC-ZAG HT Survey Q3/2017 Notably, $2.9 billion were raised in 278 VC-backed deals in the first nine months of 2017, 77 percent of total capital raised in this period, compared with $2.6 billion (68 percent) raised in 302 deals in the corresponding period in 2016. Deals above $20 million attracted the largest share of capital raised in VC-backed deals, with approximately 60 percent of the total dollar amount in Q1-Q3/2017. The average VC-backed financing round has been continuously increasing over the past five years to peak at $10.4 million in Q1- Q3/2017, compared with $8.4 million in Q1-Q3/2016. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 8

Capital Raised by Round $433m record for B round The largest capital amount was raised in later rounds $638 million in Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 9

Capital raised by round Q3/2017 In Q3/2017, the number of seed and A rounds experienced a moderate decrease s of 23 percent and 28 percent, respectively - compared with the quarterly two-year averages. Moreover, the amount attracted in A rounds was 27 percent below the two-year average. B rounds accounted for $433 million in Q3/2017, placing second among all stages, the same as in Q2/2017. The amount was 75 percent above the three-year quarterly average. C round capital raising decreased further in Q3/2017, in line with the previous weak quarter, to 19 percent below the two-year quarterly average. Later rounds accounted for a notable $638 million in Q3/2017, with number of deals unchanged at 40 (equal to the average of three past years). 2017/3 40 173 433 155 638 2017/2 65 243 280 163 515 2017/1 37 213 163 285 363 2016/4 43 228 210 100 492 2016/3 26 241 156 145 365 2016/2 38 302 271 261 842 2016/1 55 265 106 234 451 2015/4 83 162 191 200 492 2015/3 69 157 223 200 387 2015/2 46 208 390 164 333 $m 2015/1 58 102 294 181 366 Source: IVC-ZAG HT Survey Q3/2017 0 200 400 600 800 1000 1200 1400 1600 1800 Seed A Round B round C round Later rounds @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 10

Total Capital $m Capital raised by round Q1-Q3/2017 Noticeably fewer seed rounds were made in Q1-Q3/2017 105 transactions, a decrease of 15 percent from the five-year average for this period. Nonetheless, the amount of seed capital raised was unchanged at the level of the three-year average for this period. The number of A round deals (109) in Q1-Q3/2017 returned to the average of the previous three years. In the first nine months of 2017, B round financing regained its second position, both in terms of amount and the number of deals. Later rounds were the strongest in Q1-Q3/2017, accounting for 40 percent of total capital. 4000 34 35 3500 30 3000 2500 2000 1500 1000 500 0 20 1,053 1,086 18 1,658 545 639 1,517 685 189 532 876 908 10 7 219 480 333 808 5 457 467 628 284 62 126 173 119 141 0 Q1-Q3/2013 Q1-Q3/2014 Q1-Q3/2015 Q1-Q3/2016 Q1-Q3/2017 Seed A round Source: IVC-ZAG HT Survey Q3/2017 B round C round Later rounds # of deals >$20m in later rounds 21 603 25 20 15 # of deals above $20m @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 11

Capital Raised by Deal Size <$5m -32% from 5-year average Deals above $20M continue to lead in Q1-Q3/2017 57 deals accounted for 57% of total amount @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 12

Capital raised by deal size Q3/2017 In Q3/2017, deals of less than $5 million continued to shrink, with 79 transactions attracting just $107 million. The amount composed just 7 percent share of total capital (below the 17 percent five-year quarterly average ). Capital raising in deals ranging from $5 million to $10 million improved in Q3/2017, when $190 million were raised in 26 deals. Deals ranging from $10 million to $20 million continued their capital raising pace in Q3/2017. In Q3/2017, 63 percent of total capital went to deals of over $20 million each. The Via Transportation deal ($250 million) accounted for 28 percent of this amount. $m # 1,800 1,600 200 1,400 1,200 136 1,017 150 1,000 800 600 116 118 551 560 117 649 430 118 574 111 88 517 118 573 98 546 689 96 904 79 100 400 200-280 224 331 238 143 224 241 273 239 211 158 171 244 214 90 147 95 158 104 139 146 190 149 144 132 198 152 172 114 171 127 165 107 2015/1 2015/2 2015/3 2015/4 2016/1 2016/2 2016/3 2016/4 2017/1 2017/2 2017/3 50 0 <$5M $5M-$10M $10M-$20M >$20M # of Deals <$5M Source: IVC-ZAG Survey Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 13

Capital raised by deal size Q1-Q3/2017 Q1-Q3/2017 Q1-Q3/2016 Q1-Q3/2015 Q1-Q3/2014 Q1-Q3/2013 753 475 399 661 549 439 593 400 425 868 574 374 487 311 513 329 429 1,760 2,139 2,107-500 1,000 1,500 2,000 2,500 3,000 >$20M $10M-$20M $5M-$10M <5M Source: IVC-ZAG Survey Q3/2017 Deals of less than $5 million have been decreasing over the four past years, reaching the lowest number (273) in Q1-Q3/2017. Interestingly, the number of life sciences deals ranging from $5 million to $10 million increased 50 percent from Q1-Q3/2016, reaching 34 percent in the same period of 2017, with $164 million, the highest amount for this sector, almost equal to software figures. In Q1-Q3/2017, there was an upsurge in B and later round deals ranging from $10 million to $20 million, to a record $308 million and $243 million, respectively. In Q1-Q3/2017, deals of over $20 million led all capital raising with the record amount of $2.14 billion, slightly above the previous record of $2.11 billion from the same period in 2016. In Q1-Q3/2017, deals of over $20 million led all capital raising with the record amount of $2.14 billion, slightly above the previous record of $2.11 billion from the corresponding period in 2016. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 14

Capital Raised by Sector Q3/2017 Software -15% Software & life sciences lead capital raising in Q1-Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 15

Total Capital $m Capital raised by sector Q3/2017 1800 1600 11 81 148 1400 17 130 1200 537 116 19 43 51 17 95 8 69 54 1000 163 348 66 41 66 109 36 31 257 102 42 42 49 388 325 13 18 800 259 223 165 39 176 323 323 213 235 12 38 204 11 16 500 361 600 104 188 381 137 257 29 162 284 406 382 244 299 382 490 20 66 130 411 400 19 3 188 155 91 137 112 340 172 259 596 129 255 244 297 115 137 56 85 171 216 207 141 200 229 162 106 146 152 277 69 116 68 79 82 168 75 104 81 36 56 61 107 119 168 69 35 97 119 66 20 28 23 13 26 5 18 16 73 126 73 87 0 18 54 38 16 40 1/13 2/13 3/13 4/13 1/14 2/14 3/14 4/14 1/15 2/15 3/15 4/15 1/16 2/16 3/16 4/16 1/17 2/17 3/17 Semiconductors Miscellaneous Technologies Life Sciences IT & Enterprise Software Internet Communications Cleantech Source: IVC-ZAG Survey Q3/2017 111 In Q3/2017, 41 software companies led all capital raising, as in previous four quarters. The amount and the share of capital (just 25 percent), however, were the lowest for this sector in the past two years. Security was the most attractive subsector in Q3/2017, with 38 percent share of the entire software capital raised. Life sciences companies closely followed with $348 million (24 percent) in 39 deals, the second highest amount in the past two years. The number of deals was 15 percent above the quarterly two-year average. Medical devices companies accounted for 50 percent of the entire capital raised by the life sciences in Q3/2017. Q3/2017 was the best quarter for communications companies since Q3/2016, with $277 million (19 percent) raised in 18 deals. This was mostly due to the exceptional $250 million late round by Via Transportation, which boosted the Q3/2017 results. Twenty-four Internet companies raised $172 million (12 percent) in Q3/2017. Internet applications led all Internet capital raising with 49 percent of total capital. The number of deals was close to the quarterly average of 2017. In Q3/2017, 13 other technologies transactions accounted for $130 million (9 percent). The capital share was somewhat above the two-year quarterly average of 6 percent. Semiconductors capital raising increased in Q3/2017, reaching $111 million, or 8 percent of total capital. In terms of number of deals, the quarterly average stayed at the two-year quarterly average. Six cleantech deals followed with $40 million (3 percent) in Q3/2017, above the mere $16 million (1 percent) the sector attracted in Q2/2017. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 16

Average financing $m Capital raised by sector Q3/2017 Contd. 40.00 35.00 30.00 25.00 20.00 15.00 10.00 5.00 0.00 1/15 2/15 3/15 4/15 1/16 2/16 3/16 4/16 1/17 2/17 3/17 Cleantech Communications Internet Source: IVC-ZAG Survey Q3/2017 IT & Enterprise Software Life Sciences Miscellaneous Technologies Semiconductors @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 17

Capital raised by sector Q1-Q3/2017 $m Q1-Q3/2017 93 437 470 1263 971 295 236 Q1-Q3/2016 145 766 625 1301 686 162 70 Q1-Q3/2015 120 312 813 987 710 111126 Q1-Q3/2014 64 249 539 602 556 203 92 Q1-Q3/2013 127 228 325 305 357 51 189 0 500 1000 1500 2000 2500 3000 3500 4000 Source: IVC-ZAG Survey Q3/2017 Cleantech Communications Internet IT & Enterprise Software Life Sciences Miscellaneous Technologies Semiconductors In Q1-Q3/2017, software and the life sciences led all capital raising, with the life sciences accounting for the record amount for this sector. The number of software deals kept its lead, as in the corresponding period of 2016, with 150 transactions, 33 percent of all deals. Internet capital raising shrank even further in Q1-Q3/2017, both in terms of capital and in the number of deals. Communications continued to shrink throughout Q1-Q3/2017, hitting the lowest share in past five years for this period - 6 percent of total capital, with the number of deals 35 percent below the average of the same period in the past five years. Q1-Q3/2017 was better for semiconductors, as capital raising increased, and more deals were made. The number of deals in the other technologies sector grew 54 percent, resulting in a noticeable increase compared with the first nine months of the past five years. Cleantech accounted for the remaining 3 percent share of total capital raised in Q1- Q3/2017; the number of deals in this period was 23 percent below the five-year average. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 18

Capital Raised by Stage Less seed & early stage deals in Q1-Q3/2017 Late stage lead capital raising with $618 million in Q3/2017 1 st time in 5 quarters @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 19

Quarterly capital raising by stage Almost half (43 percent) of the total capital raised in Q3/2017 was invested in late stage companies, reaching a record of $618 million, compared with $425 million in Q2/2017 and $294 million in Q3/2016. The $250 million Via Transportation mega-deal significantly increased the share of this stage in Q3/2017. This also caused an upsurge in the average financing in late stage, which peaked at $33 million. Noticeably fewer deals were made in mid-stage companies 15 percent below the three-year quarterly average. At 30 percent, the share of capital raised by mid-stage companies was also down, below the four previous quarters. In Q3/2017, deals in early stage kept their pace, with the number of transactions (43) almost equal to the two-year quarterly average, and the share of total capital in this quarter remained at the average of 24 percent. Still, early stage attracted more capital - $352 million - compared with $238 million in Q3/2016. Seed companies capital raising showed poor results in Q3/2017, with both the number of deals (30) and the amount below the quarterly averages of the past five years. Seed stage, however, maintained the same 3 percent share of total capital raised as in Q3/2016. 800 726 618 700 534 425 600 500 400 300 200 100 0 296 328 480 517 426 349 478 374 468 406 407 391 352 408 309 294 264 376 321 233 312 428 238 199 304 319 266 241 65 43 211 42 35 90 70 41 27 88 2017/1 2017/22017/3 2016/4 59 43 2016/3 2016/2 2016/1 2015/4 2015/3 Source: IVC-ZAG Survey Q3/2017 2015/2 2015/1 2015/1 2015/2 2015/3 2015/4 2016/1 2016/2 2016/3 2016/4 2017/1 2017/2 2017/3 Seed 59 43 88 90 70 41 27 42 35 65 43 R&D 319 211 266 241 312 428 238 264 199 309 352 Initial Revenues 328 408 376 391 407 517 374 534 478 468 426 Revenue Growth 296 480 304 406 321 726 294 233 349 425 618 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 20

Capital raising by stage Q1-Q3/2017 Late stage companies led all capital raising, capturing 37 percent of the total amount, closely followed by mid-stage companies, with a 36 percent share in Q1-Q3/2017. Both stages were strong, improving slightly from 2016 in capital raised. Mid-stage kept leading all stages in the number of deals (179), while 56 deals in late stage were in line with the past four years. In Q1-Q3/2017, joint seed and early stage deal-making was 17 percent down from the five-year average for this period, while the amounts raised in each stage were above the averages. Seed also kept its share of capital at 4 percent, as in 2016. Q1-Q3/2017 143 860 1,372 1,391 Q1-Q3/2016 138 979 1,299 1,341 Q1-Q3/2015 190 797 1,112 1,079 Q1-Q3/2014 139 648 569 949 Q1-Q3/2013 76 402 839 266-500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 Seed R&D Initial Revenues Revenue Growth Source: IVC-ZAG Survey Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 21

# of deals Capital raising by stage Q1-Q3/2017 IVC findings show a decline in the numbers of deals made in the first nine months of 2017. The IVC analysis found that most of this decrease stems from seed and early stage deals. 350 300 250 200 150 100 50 258 184 31 293 290 265 222 189 179 164 153 57 50 54 56 0 Q1-Q3/2013 Q1-Q3/2014 Q1-Q3/2015 Q1-Q3/2016 Q1-Q3/2017 Source: IVC-ZAG Survey Q3/2017 Seed & R&D Initial Revenues Revenue Growth @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 22

Israeli VC Funds Investment Activity First investments at $252m in Q1-Q3/17 Israeli VC funds invested $227 million in Q3/2017 the highest in 5 quarters @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 23

Israeli VC funds investments Q3/2017 $m 250 246 227 100% 90% 200 198 198 191 80% 150 138 119 162 151 137 125 173 126 129 58% 138 71% 139 129 52% 164 50% 66% 70% 60% 50% 100 74% 44% 75% 79% 99 58% 75% 60% 81% 66% 63% 71% 69% 64% 55% 40% 30% 50 20% 0 26% 56% 25% 21% 42% 25% 40% 19% 34% 37% 29% 42% 31% 29% 36% 45% 48% 50% 34% 10% 0% First Investments % Follow-on Investments % Israeli VC fund investments $m Source: IVC-ZAG Survey Q3/2017 Israeli VC fund investments increased in Q3/2017, with $227 million invested (16 percent of total capital), compared with $164 million (13 percent) and $139 million (15 percent) in Q2/2017 and Q3/2016, respectively. Israeli VC funds preferred follow-on investments (66 percent) in Q3/2017, with most of this capital (91 percent) going to mid and late-stage companies. In Q3/2017, the first investment average reached $1.1 million, and the average follow-on investment was up as well, at $2.02 million. Israeli VC fund participated in 45 percent of deals in Q3/2017. Interestingly, just 36 percent of capital was raised in deals without involvement of Israeli VC funds in Q3/2017, compared with the five-year quarterly average share of 50 percent. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 24

Israeli VC funds investments Q1-Q3/2017 100% 90% 80% 1.03 1.27 1.4 # 1.2 70% 60% 50% 0.89 74% 84% 0.72 0.85 87% 86% 85% 1 0.8 40% 0.6 30% 0.4 20% 10% 0% 26% 16% 13% 14% 15% 0 Q1-Q3/2013 Q1-Q3/2014 Q1-Q3/2015 Q1-Q3/2016 Q1-Q3/2017 Israeli VC fund investments $m Source: IVC-ZAG Survey Q3/2017 Other investments $m Average Israeli VC fund investments $m 0.2 The capital invested by Israeli VC funds has steadily increased over the past four years, reaching $582 million in Q1-Q3/2017, growing 11 percent from the $523 million invested in Q1- Q3/2016. Yet, their share of total capital stayed stable and modest. In Q1-Q3/2017, the number of deals involving Israeli VC funds shrank to 183 transactions, a decrease of 11 percent from the average for this period in past five years. This was due to the 23 percent decline in follow-on investments by Israeli VC funds. Israeli VC funds enlarged their first investments in Q1-Q3/2017, placing $252 million in 81 transactions, an upsurge of 53 percent in amount and almost 8 percent in the number of deals, compared with the averages of the past five years for this period. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 25

Capital Raised From Investors: Israeli vs. Foreign 42% $1.58 billion were raised from Israeli investors in Q1-Q3/2017 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 26

Capital raising from Israeli vs. foreign investors $m 1,800 1,600 1,400 1,200 1,000 800 600 400 200-439 53% 481 51% 663 43% 821 40% 672 52% 934 31% 699 39% 1,142 1,104 1,129 1,110 1,001 1,035 23% 38% 29% 41% 37% 38% 1,714 933 1,073 1,060 47% 49% 57% 60% 48% 69% 61% 62% 62% 77% 71% 59% 63% 64% 57% 68% 57% 55% 62% 36% 43% 32% 43% 1,266 45% 1,439 38% 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% % of Foreign Investors ($m) % of Israeli Investors ($m) Source: IVC-ZAG Survey Q3/2017 In Q3/2017, the majority of capital invested in Israeli high-tech companies - $885 million - came from foreign investors, while Israeli investors were responsible for $554 million. Both amounts were above the quarterly averages of past three years, increasing 20 percent and 28 percent, respectively. In the first three quarters of 2017, foreign investors led capital investments, with $2.19 billion (58 percent), some 6 percent below the $2.32 billion invested in the corresponding period of 2016. Investments by Israeli investors actually increased throughout the first three quarters each year, peaking at $1.58 billion in Q1- Q3/2017. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 27

Methodology This survey reviews capital raised by Israeli high-tech companies from Israeli and foreign venture capital funds, as well as other investors, such as investment companies, corporate investors, incubators, and angels. The survey is based on reports from 378 investors, of which 52 were Israeli VC management companies and 326 were other entities. The survey covered total investment in the Israeli venture capital sector, including both VC-backed rounds where at least one investor participating in the round was a VC fund, as well as deals not backed by venture capital funds. The survey includes amounts received by each company directly, and doesn't count direct transactions performed between companies' shareholders. For more on our methodology, please visit Survey methodology webpage. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 28

About IVC Research Center IVC Research Center is the leading online provider of data and analyses on Israel s high-tech, venture capital and private equity industries. Its information is used by all key decision-makers, strategic and financial investors, government agencies and academic and research institutions in Israel. IVC-Online Database (www.ivc-online.com) showcases over 16,000 Israeli technology startups, and includes information on private companies, investors, venture capital and private equity funds, angel groups, incubators, accelerators, investment firms, professional service providers, investments, financings, exits, acquisitions, founders, key executives and R&D centers. Publications include newsletters; Daily Alerts; the IVC High-Tech Yearbook the Israel High-Tech, Venture Capital, Startup and Private Equity Directory; surveys; research papers and reports; and interactive dashboards IVC Industry Analytics analysis, research and insights into the status, main trends and opportunities related to exits, investments, investors, sectors and stages @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 29

About ZAG-S&W ZAG-S&W (Zysman, Aharoni, Gayer & Co.) is an international law firm operating out of offices in Israel, the United States, China and the United Kingdom. The firm s attorneys specialize in all disciplines of commercial law for both publicly held and private companies, with particular expertise in hi-tech, life science, international transactions and capital markets. ZAG-S&W provides result-driven legal and business advice to its clients, addressing all aspects of the clients business activities, including penetration into new markets in strategic locations. In recent years the firm has acted on a majority of the equity and debt financing transactions by Israeli technology companies on the NASDAQ. It has been the firm's experience that the best results, those that give our clients the competitive advantage they need, are attained by coupling professional experience, global presence, and connections with the investor communities in Israel and abroad. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 30

Copyright The information contained in this report is derived from IVC- Online - the IVC Research Center Ltd. ("IVC") Database and the IVC-ZAG Israeli High-Tech Survey. This report is copyrighted, no part of the material in this report (including, but not limited to text, content, and images) may be reproduced, republished or utilized in any form or by any means without the explicit and prior written consent of IVC. @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 31

Contact Us Marianna Shapira Research Director, IVC Research Center marianna@ivc-online.com www.ivc-online.com +972-(0)73-212-2339 @ ALL RIGHTS RESERVED. COPYRIGHT OF IVC RESEARCH CENTER LTD. 2017 32